Skip to main content
. 2021 Sep 15;7(9):e07993. doi: 10.1016/j.heliyon.2021.e07993

Figure 5.

Figure 5

Changes in investigators assessed severity score of AAD related symptoms at different time points both in pediatric [Placebo-PS (♦) and Test-PS (◊)] and adolescent and adult [Placebo-AA (■;) and Test-AA (□)] groups.